PACTR201812717126560

Comparison between subcision followed by 35% TCA versus subcision followed by microneedling in the treatment of acne scars: a prospective comparative study.

Dermatology department·Phase 4·Pan Africa Clinical Trials Registry·otherCompleted
Study focus
Intervention type
other
Sponsor & location
Primary sponsor
Dermatology department
Funder
Sarah Orabi
Location
Egypt
Timeline & enrollment
Phase
Phase 4
Start date
Jan 01, 1900
End date
Jan 01, 1900
Summary

Background:Acne scars treatment is difficult and challenging because of the variety in the acne scars morphology and the limited ability of the available treatment options to improve the scars. Multiple treatment modalities are used and each has its unique place in the treatment plan. Subcision is a non operative procedure that aims to break the fibrous strands that tether the scar to the underlying subcutaneous tissue, in which a needle is inserted through a puncture in the skin surface and passed in multiple directions to create a pocket under the scar to release the fibrous attachments.Microneedling, which is also known as percutaneous collagen induction therapy or needle dermabrasion, is a skin resurfacing procedure which involves the use of fine needles that create micro skin wounds. Trichloroacetic acid (TCA) causes protein denaturation named keratocoagulation resulting in white frost. 35% is used for medium depth peeling.Objective:To compare the efficacy and safety of both combined subcision and microneedling versus combined subcision and peeling in the treatment of acne scars.

ICD-10 classifications
Systemic disorders of connective tissue in diseases classified elsewhereSystemic disorders of connective tissue in other diseases classified elsewhereDiseases of the skin and subcutaneous tissueOther disorders of skin and subcutaneous tissue in diseases classified elsewhereOther disorders of the skin and subcutaneous tissue
Data source
Registry
Pan Africa Clinical Trials Registry
Trial ID
PACTR201812717126560
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for PACTR201812717126560 through Pure Global AI's free database. This Phase 4 trial is sponsored by Dermatology department and is currently Completed. The study focuses on Skin and Connective Tissue Diseases.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.